Tang Capital Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Tang Capital Management’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,641,945	Closed	-$879K	–	208
2024 Q4	$879K	Sell	1,641,945 -3,058,055	-65%	-$2.13M	0.06%	160
2024 Q3	$8.27M	Sell	4,700,000 -100,000	-2%	-$140K	0.59%	51
2024 Q2	$5.62M	Buy	+4,800,000	New	+$12M	0.57%	54

Tang Capital Management's MRNS Position: Q1 2025 in Review

Tang Capital Management sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2025, closing a stake of 1,641,945 shares — an estimated $879K sold.

Tang Capital Management first reported a position in MRNS in Q2 2024 and held it in 3 quarters. The position peaked at $8.27M in Q3 2024. 0 funds tracked by Wall St. Rank hold MRNS as of Q1 2025.

Tang Capital Management reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2025 after selling out during the quarter.
Tang Capital Management sold 1,641,945 Marinus Pharmaceuticals, Inc shares in Q1 2025, an estimated $879K.
Tang Capital Management first reported a position in Marinus Pharmaceuticals, Inc in Q2 2024 and held it in 3 quarters.
Tang Capital Management's Marinus Pharmaceuticals, Inc position peaked at $8.27M in Q3 2024.
0 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2025.

Based on Tang Capital Management's 13F filing for Q1 2025, filed 15 May 2025.